Lite Strategy (LITS) Price to FCF (2010 - 2026)
Lite Strategy (LITS) posted Price to FCF of 26.83 for Q1 2026, down 7.83% on a QoQ basis from 24.88 in Q4 2025, and down 500.69% year-over-year from 6.7 in Q1 2025.
Analysis
Lite Strategy (LITS) Price to FCF (2010 - 2026) Analysis & Trends
Lite Strategy has reported Price to FCF for 17 years, with the latest figure at 26.83 in Q1 2026.
- On a quarterly basis, Price to FCF fell 500.69% year-over-year to 26.83 in Q1 2026; TTM through Mar 2026 was 0.37, a 7.91% increase from a year earlier, with the FY2025 full-year figure at 0.79, down 105.56% from the prior year.
- Price to FCF was 26.83 for Q1 2026 at Lite Strategy, down from 24.88 in the prior quarter.
- The five-year high for Price to FCF was 0.68 in Q3 2025, with the low at 26.83 in Q1 2026.
- Average Price to FCF over 5 years is 6.34, with a median of 3.87 recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Price to FCF jumped 94.53% in 2022, then sank 520.78% in 2025.
- Over 5 years, Price to FCF stood at 2.25 in 2022, then sank by 55.28% to 3.5 in 2023, then retreated by 27.9% to 4.47 in 2024, then slumped by 456.52% to 24.88 in 2025, then retreated by 7.83% to 26.83 in 2026.
- The last three Price to FCF figures came in at 26.83 (Q1 2026), 24.88 (Q4 2025), and 0.68 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -26.83 |
| Dec 31, 2025 | -24.88 |
| Sep 30, 2025 | -0.68 |
| Jun 30, 2025 | -6.69 |
| Mar 31, 2025 | -4.47 |
| Dec 31, 2024 | -4.47 |
| Sep 30, 2024 | -1.66 |
| Jun 30, 2024 | -1.08 |
| Mar 31, 2024 | -9.10 |
| Dec 31, 2023 | -3.50 |
| Sep 30, 2023 | -2.53 |
| Jun 30, 2023 | -3.87 |
| Mar 31, 2023 | -2.53 |
| Dec 31, 2022 | -2.25 |
| Sep 30, 2022 | -3.50 |
| Jun 30, 2022 | -5.14 |
| Mar 31, 2022 | -4.68 |
| Dec 31, 2021 | -41.18 |
| Sep 30, 2021 | -40.24 |
| Jun 30, 2021 | -28.49 |